Differential expression of choline kinase isoforms in skeletal muscle explains the phenotypic variability in the rostrocaudal muscular dystrophy mouse-Reference-Cited by-同舟云学术

Differential expression of choline kinase isoforms in skeletal muscle explains the phenotypic variability in the rostrocaudal muscular dystrophy mouse

Published:2010-04 Issue:4 Volume:1801 Page:446-454
ISSN:1388-1981
Container-title:Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
language:en
Short-container-title:Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids

Author:

Wu Gengshu,Sher Roger B.,Cox Gregory A.,Vance Dennis E.

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology

Reference46 articles.

1. Molecular basis of muscular dystrophies;Cohn;Muscle Nerve,2000

2. A rostrocaudal muscular dystrophy caused by a defect in choline kinase beta, the first enzyme in phosphatidylcholine biosynthesis;Sher;J. Biol. Chem.,2006

3. Phosphorylcholine: a novel second messenger essential for mitogenic activity of growth factors;Cuadrado;Oncogene,1993

4. Structure and function of choline kinase isoforms in mammalian cells;Aoyama;Prog. Lipid Res.,2004

5. Actinomycin D-sensitive induction of choline kinase by carbon tetrachloride intoxication in rat liver;Ishidate;Biochem. Biophys. Res. Commun.,1983

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. GDE5/Gpcpd1 activity determines phosphatidylcholine composition in skeletal muscle and regulates contractile force in mice;Communications Biology;2024-05-20

2. Defects in integrin complex formation promoteCHKB-mediated muscular dystrophy;Life Science Alliance;2024-05-15

3. Skeletal Muscle Regeneration in Cardiotoxin-Induced Muscle Injury Models;International Journal of Molecular Sciences;2022-11-02

4. Histopathology is required to identify and characterize myopathies in high-throughput phenotype screening of genetically engineered mice;Veterinary Pathology;2021-07-16

5. Choline Kinase: An Unexpected Journey for a Precision Medicine Strategy in Human Diseases;Pharmaceutics;2021-05-25